Kallmann R et al. |
Effects of low doses of aspirin, 10 mg and 30 mg daily, on bleeding time, thromboxane production and 6-keto-PGF1 alpha excretion in healthy subjects. |
1987 |
Thromb. Res. |
pmid:3576521
|
Filep J and Rosenkranz B |
Mechanism of vasopressin-induced platelet aggregation. |
1987 |
Thromb. Res. |
pmid:3105115
|
Svensson J and Samuelsson K |
Inhibition of platelet function by low dose acetylsalicylic acid in patients with cerebrovascular disease. |
1983 |
Thromb. Res. |
pmid:20218005
|
Weide I and Simmet T |
Leukotriene formation by peripheral monocytes in contact-activated human blood. |
1993 |
Thromb. Res. |
pmid:8211886
|
Takasaki W et al. |
Superiority of plasma 11-dehydro-TXB2 to TXB2 as an index of in vivo TX formation in rabbits after dosing of CS-518, a TX synthase inhibitor. |
1993 |
Thromb. Res. |
pmid:8367836
|
Saldeen P et al. |
Increased synthesis of thromboxane B2 and 6-keto-PGF1 alpha in hand veins from patients with deep venous thrombosis. |
1983 |
Thromb. Res. |
pmid:6658723
|
Watanabe T et al. |
Enhanced platelet sensitivity to prostacyclin in patients in an active stage of Takayasu arteritis. |
2001 |
Thromb. Res. |
pmid:11672751
|
Ziegler BK et al. |
Incomplete thromboxane inhibition with 100 mg of intravenous acetylsalicylic acid in patients with acute ST elevation myocardial infarction: a placebo-controlled pilot trial. |
2001 |
Thromb. Res. |
pmid:11672759
|
Ljungberg B et al. |
Immediate effects of heparin and LMW heparin on some platelet and endothelial derived factors. |
1988 |
Thromb. Res. |
pmid:2847353
|
Boyd JA and Eling TE |
Prostaglandin release and the interaction of platelets with the pulmonary vasculature of rat and guinea pig. |
1980 Jul 1-15 |
Thromb. Res. |
pmid:7003800
|
Martin JF et al. |
Effect of acetylsalicylic acid on platelet aggregation and thromboxane B2 production in flowing aortic blood in the rat studied with a filter loop technique. |
1982 |
Thromb. Res. |
pmid:6814004
|
Kawamura M et al. |
Evaluation of plasma 11-dehydro-thromboxane B2 as an indicator for thromboxane A2 synthesis in vivo in laboratory animals. |
1995 |
Thromb. Res. |
pmid:7778061
|
Winter M et al. |
Synthesis of thromboxane B2 in uraemia and the effects of dialysis. |
1983 |
Thromb. Res. |
pmid:6868024
|
Pedersen AK et al. |
Inhibition of thromboxane biosynthesis in serum: limitations of the measurement of immunoreactive 6-keto-PGF1 alpha. |
1984 |
Thromb. Res. |
pmid:6546456
|
Teng CM et al. |
Two antiplatelet agents from Magnolia officinalis. |
1988 |
Thromb. Res. |
pmid:3413728
|
Addonizio VP et al. |
Inhibition of human platelet function by verapamil. |
1982 |
Thromb. Res. |
pmid:7164035
|
Pekonen F et al. |
Platelet function and coagulation in normal and preeclamptic pregnancy. |
1986 |
Thromb. Res. |
pmid:2944245
|
Vargaftig BB et al. |
Adrenaline and PAF-acether synergize to trigger cyclooxygenase-independent activation of plasma-free human platelets. |
1982 |
Thromb. Res. |
pmid:7164036
|
Vlodavsky I et al. |
Platelet interaction with the extracellular matrix produced by cultured endothelial cells: a model to study the thrombogenicity of isolated subendothelial basal lamina. |
1982 |
Thromb. Res. |
pmid:7179215
|
Saldeen P et al. |
Thromboxane production in umbilical vein grafts. |
1984 |
Thromb. Res. |
pmid:6546814
|
Cholette JM et al. |
Aspirin resistance following pediatric cardiac surgery. |
2010 |
Thromb. Res. |
pmid:20550971
|
Umemura K et al. |
Effect of dietary docosahexaenoic acid in the rat middle cerebral artery thrombosis model. |
1995 |
Thromb. Res. |
pmid:7660354
|
Davì G et al. |
Thromboxane B2 formation and platelet sensitivity to prostacyclin in insulin-dependent and insulin-independent diabetics. |
1982 |
Thromb. Res. |
pmid:6761893
|
Cerskus AL et al. |
Effects of indomethacin and sulfinpyrazone on in vivo formation of thromboxane B2 and prostaglandin D2 during arachidonate infusion in rabbits. |
1978 |
Thromb. Res. |
pmid:653641
|
Hernández R et al. |
Influence of co-incubation and cell number of platelets and polymorphonuclear leukocytes in cellular inhibition and activation phenomena. |
1994 |
Thromb. Res. |
pmid:8042192
|
Hanasaki K and Arita H |
Characterization of a new compound, S-145, as a specific TXA2 receptor antagonist in platelets. |
1988 |
Thromb. Res. |
pmid:2839912
|
Navran SS et al. |
Human platelet activation by bacterial phospholipase C is mediated by phosphatidylinositol hydrolysis but not generation of phosphatidic acid: inhibition by a selective inhibitor of phospholipase C. |
1984 |
Thromb. Res. |
pmid:6372157
|
Shorr RI et al. |
In vitro effects of acetaminophen and its analogues on human platelet aggregation and thromboxane B2 synthesis. |
1985 |
Thromb. Res. |
pmid:3923647
|
Vanags D et al. |
The antiplatelet effect of daily low dose enteric-coated aspirin in man: a time course of onset and recovery. |
1990 |
Thromb. Res. |
pmid:2264023
|
Cerskus AL et al. |
Thromboxane B2 and 6-keto-prostaglandin F1 alpha synthesis during infusion of collagen and arachidonic acid in rabbits: inhibition by aspirin and sulfinpyrazone. |
1980 |
Thromb. Res. |
pmid:7414555
|
Castaldi PA et al. |
Evidence for a platelet membrane defect in the myeloproliferative syndromes. |
1982 |
Thromb. Res. |
pmid:6960545
|
Gachályi B et al. |
In vitro effect of cimetidine on ADP induced platelet aggregation and thromboxane A2 synthesis in man. |
1984 |
Thromb. Res. |
pmid:6474407
|
Fitzpatrick F et al. |
Development of a gas chromatographic-mass spectrometric method using a stable isotope internal standard for quantitation of thromboxane B2. |
1984 |
Thromb. Res. |
pmid:6474413
|
Kankuri E et al. |
Effects of phenacetin and its metabolite p-phenetidine on COX-1 and COX-2 activities and expression in vitro. |
2003 |
Thromb. Res. |
pmid:14592552
|
Lages B and Weiss HJ |
Inhibition of human platelet function in vitro and ex vivo by acetaminophen. |
1989 |
Thromb. Res. |
pmid:2499947
|
Küster LJ et al. |
Mechanism of PAF-induced platelet aggregation in man. |
1986 |
Thromb. Res. |
pmid:3764802
|
Dalli E et al. |
Effects of hawthorn (Crataegus laevigata) on platelet aggregation in healthy volunteers. |
2011 |
Thromb. Res. |
pmid:21737127
|
Ishii H et al. |
The effect of plasma on platelet function in hypercholesterolemic rabbits and the changes in fatty acid composition of the plasma. |
1984 |
Thromb. Res. |
pmid:6234679
|
Reimers HJ et al. |
Impaired thromboxane synthesis in preactivated human blood platelets: agonist-specific, irreversible desensitization to thrombin. |
1987 |
Thromb. Res. |
pmid:3126557
|
Perneby C et al. |
Prothrombotic responses to exercise are little influenced by clopidogrel treatment. |
2004 |
Thromb. Res. |
pmid:15381386
|
Lukasik M et al. |
Aspirin treatment influences platelet-related inflammatory biomarkers in healthy individuals but not in acute stroke patients. |
2011 |
Thromb. Res. |
pmid:21788065
|
Davis RB et al. |
Evaluation of platelet function in pregnancy. Comparative studies in non-smokers and smokers. |
1987 |
Thromb. Res. |
pmid:2955542
|
Ali M et al. |
Synthesis of prostaglandin D2 and thromboxane B2 by human platelets. |
1977 |
Thromb. Res. |
pmid:918907
|
Reis F et al. |
The peripheral serotonergic system and platelet aggregation in cyclosporin A-induced hypertensive rats. |
1999 |
Thromb. Res. |
pmid:10605951
|
Riess H et al. |
Effects of BM 13.177, a new antiplatelet drug in patients with atherosclerotic disease. |
1984 |
Thromb. Res. |
pmid:6237460
|
Udvardy M et al. |
Alterations of primary haemostasis in mixed connective tissue disease (MCTD). |
1991 |
Thromb. Res. |
pmid:1835548
|
Patrono C et al. |
Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects. |
1980 Feb 1-15 |
Thromb. Res. |
pmid:7368167
|
Lin CH et al. |
HA-29: an inhibitor of thromboxane A2 formation with antagonism of thromboxane A2/prostaglandin endoperoxide receptor in rabbit platelets. |
1992 |
Thromb. Res. |
pmid:1412184
|
Koh H et al. |
A radioimmunoassay of thromboxane B2 with thromboxane B2-125I-tyramide and its application to the study on the thromboxane B2 formation during platelet aggregation. |
1980 Feb 1-15 |
Thromb. Res. |
pmid:7368170
|
Kohda N et al. |
Effect of cilostazol, a phosphodiesterase III inhibitor, on experimental thrombosis in the porcine carotid artery. |
1999 |
Thromb. Res. |
pmid:10593428
|
Marasini B et al. |
Cigarette smoking and platelet function. |
1986 |
Thromb. Res. |
pmid:3787563
|
Matsuo T et al. |
A new thrombin inhibitor MD805 and thrombocytopenia encountered with heparin hemodialysis. |
1986 |
Thromb. Res. |
pmid:3787568
|
Deckmyn H et al. |
Prostacyclin production by whole blood from children: impairment in the hemolytic uremic syndrome and excessive formation in chronic renal failure. |
1983 |
Thromb. Res. |
pmid:6344317
|
Chakroun T et al. |
Screening for aspirin resistance in stable coronary artery patients by three different tests. |
2007 |
Thromb. Res. |
pmid:17553552
|
Simmet T and Luck W |
Clotting of whole human blood induces cysteinyl-leukotriene formation. |
1989 |
Thromb. Res. |
pmid:2549655
|
Chetty N and Bradlow BA |
The effects of a vegetarian diet on platelet function and fatty acids. |
1983 |
Thromb. Res. |
pmid:6612688
|
Neiman J et al. |
Composition of platelet phosphatidylinositol and phosphatidylcholine after ethanol withdrawal. |
1987 |
Thromb. Res. |
pmid:3603426
|
Vesterqvist O et al. |
Development of a GC-MS method for quantitation of 2,3-dinor-TxB2 and determinations of the daily urinary excretion rates in healthy humans. |
1984 |
Thromb. Res. |
pmid:6695361
|
Lee TK et al. |
Comparison of the effect of acetylsalicylic acid on platelet function in male and female patients with ischemic stroke. |
1987 |
Thromb. Res. |
pmid:3629557
|
Tanoue K et al. |
A new variant of thrombasthenia with abnormally glycosylated GP IIb/IIIa. |
1987 |
Thromb. Res. |
pmid:3629560
|
Franconi F et al. |
Effect of gamma-hydroxybutyric acid on human platelet aggregation in vitro. |
2001 |
Thromb. Res. |
pmid:11369419
|
Petroni A et al. |
Inhibition of platelet aggregation and eicosanoid production by phenolic components of olive oil. |
1995 |
Thromb. Res. |
pmid:7482432
|
De La Cruz JP et al. |
Antithrombotic potential of olive oil administration in rabbits with elevated cholesterol. |
2000 |
Thromb. Res. |
pmid:11113274
|
Barnhart MI et al. |
DDAVP: does the drug have a direct effect on the vessel wall? |
1983 |
Thromb. Res. |
pmid:6415852
|
Dembinska-Kiec A et al. |
Ticlopidine and platelet function in healthy volunteers. |
1992 |
Thromb. Res. |
pmid:1615496
|
Saldeen P and Saldeen T |
6-keto-prostaglandin F1 alpha/thromboxane B2 ratio in vascular and lung tissue. |
1983 |
Thromb. Res. |
pmid:6688484
|
Teng CM et al. |
Inhibition of thrombin- and collagen-induced phosphoinositides breakdown in rabbit platelets by a PAF antagonist--denudatin B, an isomer of kadsurenone. |
1990 |
Thromb. Res. |
pmid:2169076
|
Sandler H et al. |
Studies on the role of thromboxane in thrombin-induced pulmonary insufficiency in the rat. |
1986 |
Thromb. Res. |
pmid:3754987
|
Maguire ED and Wallis RB |
In vivo redirection of prostaglandin endoperoxides into 6-keto PGF1 alpha formation by thromboxane synthetase inhibitors in the rat. |
1983 |
Thromb. Res. |
pmid:6689221
|
Igawa T et al. |
Potentiation of anti-platelet aggregating activity of cilostazol with vascular endothelial cells. |
1990 |
Thromb. Res. |
pmid:2158154
|
Russell NH et al. |
Platelet adenine nucleotides and arachidonic acid metabolism in the myeloproliferative disorders. |
1981 |
Thromb. Res. |
pmid:6794179
|
Lagarde M et al. |
Increase of platelet thromboxane A2 formation and of its plasmatic half-life in diabetes mellitus. |
1980 |
Thromb. Res. |
pmid:7466751
|
McGill D et al. |
Platelet function and exercise-induced myocardial ischaemia in coronary heart disease patients. |
1989 |
Thromb. Res. |
pmid:2533414
|
Saloheimo P et al. |
Thromboxane and prostacyclin biosynthesis in patients with acute spontaneous intracerebral hemorrhage. |
2005 |
Thromb. Res. |
pmid:15733969
|
Vesterqvist O et al. |
In vivo production of thromboxane in acute human myocardial infarction: a preliminary study. |
1985 |
Thromb. Res. |
pmid:3992528
|
Chiang TM and Kang AH |
The effect of platelet surface protein phosphorylation on collagen-platelet interaction. |
1986 |
Thromb. Res. |
pmid:3810565
|
Teng CM et al. |
Antiplatelet actions of some coumarin compounds isolated from plant sources. |
1992 |
Thromb. Res. |
pmid:1523611
|
Hofmann D et al. |
Evidence for sustained platelet activation in patients with early postinfarction angina. |
1993 |
Thromb. Res. |
pmid:8303651
|
Toft G et al. |
Intravenously and topically applied magnesium in the prevention of arterial thrombosis. |
2000 |
Thromb. Res. |
pmid:10904104
|
Schmid P et al. |
Passive smoking and platelet thromboxane. |
1996 |
Thromb. Res. |
pmid:8907294
|
Randall MJ et al. |
UK-37, 248, a novel, selective thromboxane synthetase inhibitor with platelet anti-aggregatory and anti-thrombotic activity. |
1981 Jul 1-15 |
Thromb. Res. |
pmid:6795753
|
Selley ML et al. |
The effect of cholesterol oxidation products on human platelet aggregation. |
1996 |
Thromb. Res. |
pmid:8885139
|
Kritz H et al. |
Isradipine increases vascular prostaglandin I2-formation while the thromboxane B2-synthesis is diminished. |
1995 |
Thromb. Res. |
pmid:8610276
|
Armstrong RA et al. |
No effect of dietary trans isomers of alpha-linolenic acid on platelet aggregation and haemostatic factors in european healthy men. The TRANSLinE study. |
2000 |
Thromb. Res. |
pmid:11108899
|
De Caterina R et al. |
Long-term maintenance of thromboxane inhibition by two different aspirin regimens in patients with unstable angina. |
1990 |
Thromb. Res. |
pmid:2126400
|
Bergqvist D et al. |
The effect of inhibition of thromboxane synthesis in experimental thrombosis and hemostasis. |
1985 |
Thromb. Res. |
pmid:3838828
|
Lai LJ et al. |
Trilinolein inhibits epinephrine-induced human platelet aggregation. |
1994 |
Thromb. Res. |
pmid:7863478
|
Domoto DT et al. |
Combined aspirin and sulfinpyrazone in the prevention of recurrent hemodialysis vascular access thrombosis. |
1991 |
Thromb. Res. |
pmid:1926064
|
Weber AA et al. |
40 mg of aspirin are not sufficient to inhibit platelet function under conditions of limited compliance. |
2000 |
Thromb. Res. |
pmid:10709913
|
Wu TM et al. |
Inhibitory effect of hexapeptide (RGRHGD) on platelet aggregation. |
2000 |
Thromb. Res. |
pmid:10674405
|
Wang JP et al. |
XC 386: a new antiplatelet agent. |
1984 |
Thromb. Res. |
pmid:6438827
|
Leoncini G et al. |
In retinal vein occlusion platelet response to thrombin is increased. |
2009 |
Thromb. Res. |
pmid:19660790
|
Perneby C et al. |
Optimization of an enzyme immunoassay for 11-dehydro-thromboxane B(2) in urine: comparison with GC-MS. |
1999 |
Thromb. Res. |
pmid:10632465
|
Schorer AE and White JG |
Interleukin 1 enhances arterial thrombogenicity in vitro. |
1989 |
Thromb. Res. |
pmid:2609290
|
Küster LJ and Frölich JC |
PAF-induced platelet aggregation and TXB2 formation. |
1989 |
Thromb. Res. |
pmid:2922704
|
Driss F et al. |
Inhibition of platelet aggregation and thromboxane synthesis after intake of small amount of icosapentaenoic acid. |
1984 |
Thromb. Res. |
pmid:6098051
|
Udvardy M et al. |
Altered primary haemostasis in Conn's syndrome. |
1992 |
Thromb. Res. |
pmid:1448795
|
De la Cruz JP et al. |
Effect of erythrocytes and prostacyclin production in the effect of fructose and sorbitol on platelet activation in human whole blood in vitro. |
1997 |
Thromb. Res. |
pmid:9219331
|
Delvos U et al. |
Direct radioimmunological measurement of thromboxane B2 in plasma. |
1985 |
Thromb. Res. |
pmid:4082109
|
Swart SS et al. |
Functional significance of the platelet alpha2-adrenoceptor: studies in patients with myeloproliferative disorders. |
1984 |
Thromb. Res. |
pmid:6326344
|